|
1
|
Boyce BF and Xing L: Functions of
RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem
Biophys. 473:139–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hauschka PV, Lian JB, Cole DE and Gundberg
CM: Osteocalcin and matrix Gla protein: vitamin K-dependent
proteins in bone. Physiol Rev. 69:990–1047. 1989.PubMed/NCBI
|
|
3
|
Ducy P, Desbois C, Boyce B, Pinero G,
Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C,
Bradley A and Karsenty G: Increased bone formation in
osteocalcin-deficient mice. Nature. 382:448–452. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee NK and Karsenty G: Reciprocal
regulation of bone and energy metabolism. Trends Endocrinol Metab.
19:161–166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rosen CJ: Bone remodeling, energy
metabolism, and the molecular clock. Cell Metab. 7:7–10. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gogakos AI, Duncan Bassett JH and Williams
GR: Thyroid and bone. Arch Biochem Biophys. 503:129–136. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rizzoli R, Poser J and Burgi U: Nuclear
thyroid hormone receptors in cultured bone cells. Metabolism.
35:71–74. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kasono K, Sato K, Han DC, Fujii Y,
Tsushima T and Shizume K: Stimulation of alkaline phosphatase
activity by thyroid hormone in mouse osteoblast-like cells
(MC3T3-E1): a possible mechanism of hyperalkaline phosphatasia in
hyperthyroidism. Bone Miner. 4:355–363. 1988.
|
|
9
|
Kassem M, Mosekilde L and Eriksen EF:
Effects of triiodothyronine on DNA synthesis and differentiation
markers of normal human osteoblast-like cells in vitro. Biochem Mol
Biol Int. 30:779–788. 1993.PubMed/NCBI
|
|
10
|
Ishisaki A, Tokuda H, Yoshida M, Hirade K,
Kunieda K, Hatakeyama D, Shibata T and Kozawa O: Activation of p38
mitogen-activated protein kinase mediates thyroid
hormone-stimulated osteocalcin synthesis in osteoblasts. Mol Cell
Endocrinol. 214:189–195. 2004. View Article : Google Scholar
|
|
11
|
Kanno Y, Ishisaki A, Yoshida M, Nakajima
K, Tokuda H, Numata O and Kozawa O: Adenylyl cyclase-cAMP system
inhibits thyroid hormone-stimulated osteocalcin synthesis in
osteoblasts. Mol Cell Endocrinol. 229:75–82. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fogarty S and Hardie DG: Development of
protein kinase activators: AMPK as a target in metabolic disorders
and cancer. Biochim Biophys Acta. 1804:581–591. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hardie DG, Hawley SA and Scott JW:
AMP-activated protein kinase - development of the energy sensor
concept. J Physiol. 574:7–15. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lage R, Dieguez C, Vidal-Puig A and Lopez
M: AMPK: a metabolic gauge regulating whole-body energy
homeostasis. Trends Mol Med. 14:539–549. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Steinberg GR and Kemp BE: AMPK in health
and disease. Physiol Rev. 89:1025–1078. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou G, Myers R, Li Y, Chen Y, Shen X,
Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N,
Hirshman MF, Goodyear LJ and Moller DE: Role of AMP-activated
protein kinase in mechanism of metformin action. J Clin Invest.
108:1167–1174. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanazawa I, Yamaguchi T, Yano S, Yamauchi
M and Sugimoto T: Metformin enhances the differentiation and
mineralization of osteoblastic MC3T3-E1 cells via AMP kinase
activation as well as eNOS and BMP-2 expression. Biochem Biophys
Res Commun. 375:414–419. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shah M, Kola B, Bataveljic A, Arnett TR,
Viollet B, Saxon L, Korbonits M and Chenu C: AMP-activated protein
kinase (AMPK) activation regulates in vitro bone formation and bone
mass. Bone. 47:309–319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kato K, Tokuda H, Adachi S,
Matsushima-Nishiwaki R, Natsume H, Yamakawa K, Gu Y, Otsuka T and
Kozawa O: AMP-activated protein kinase positively regulates FGF-2-
stimulated VEGF synthesis in osteoblasts. Biochem Biophys Res
Commun. 400:123–127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kato K, Otsuka T, Kondo A,
Matsushima-Nishiwaki R, Natsume H, Kozawa O and Tokuda H:
AMP-activated protein kinase regulates PDGF-BB-stimulated
interleukin-6 synthesis in osteoblasts: involvement of
mitogen-activated protein kinases. Life Sci. 90:71–76. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim EK, Miller I, Aja S, Landree LE, Pinn
M, McFadden J, Kuhajda FP, Moran TH and Ronnett GV: C75, a fatty
acid synthase inhibitor, reduces food intake via hypothalamic
AMP-activated protein kinase. J Biol Chem. 279:19970–19976. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nam M, Lee WH, Bae EJ and Kim SG: Compound
C inhibits clonal expansion of preadipocytes by increasing p21
level irrespectively of AMPK inhibition. Arch Biochem Biophys.
479:74–81. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sudo H, Kodama HA, Amagai Y, Yamamoto S
and Kasai S: In vitro differentiation and calcification in a new
clonal osteogenic cell line derived from newborn mouse calvaria. J
Cell Biol. 96:191–198. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kozawa O, Tokuda H, Miwa M, Kotoyori J and
Oiso Y: Cross-talk regulation between cyclic AMP production and
phosphoinositide hydrolysis induced by prostaglandin E2 in
osteoblast-like cells. Exp Cell Res. 198:130–134. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kato K, Ito H, Hasegawa K, Inaguma Y,
Kozawa O and Asano T: Modulation of the stress-induced synthesis of
hsp27 and alpha B-crystallin by cyclic AMP in C6 rat glioma cells.
J Neurochem. 66:946–950. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang W, Yang N and Shi XM: Regulation of
mesenchymal stem cell osteogenic differentiation by
glucocorticoid-induced leucine zipper (GILZ). J Biol Chem.
283:4723–4729. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hawley SA, Davison M, Woods A, Davies SP,
Beri RK, Carling D and Hardie DG: Characterization of the
AMP-activated protein kinase kinase from rat liver and
identification of threonine 172 as the major site at which it
phosphorylates AMP-activated protein kinase. J Biol Chem.
271:27879–27887. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Warden SM, Richardson C, O’Donnell J Jr,
Stapleton D, Kemp BE and Witters LA: Post-translational
modifications of the beta-1 subunit of AMP-activated protein kinase
affect enzyme activity and cellular localization. Biochem J.
354:275–283. 2001. View Article : Google Scholar
|
|
30
|
Park SH, Gammon SR, Knippers JD, Paulsen
SR, Rubink DS and Winder WW: Phosphorylation-activity relationships
of AMPK and acetyl-CoA carboxylase in muscle. J Appl Physiol.
92:2475–2482. 2002. View Article : Google Scholar : PubMed/NCBI
|
